ADI-PEG-20, Troriluzole, AZD1390
GCAR-7213
Phase 3 small_molecule active
Quick answer
ADI-PEG-20, Troriluzole, AZD1390 for Oncology - Glioblastoma (GBM) is a Phase 3 program (small_molecule) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Adaptive Biotechnologies Corp
- Indication
- Oncology - Glioblastoma (GBM)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active